Literature DB >> 26402843

Proportionate Dwarfism in Mice Lacking Heterochromatin Protein 1 Binding Protein 3 (HP1BP3) Is Associated With Alterations in the Endocrine IGF-1 Pathway.

Benjamin P Garfinkel1, Shiri Arad1, Phuong T Le1, Michael Bustin1, Clifford J Rosen1, Yankel Gabet1, Joseph Orly1.   

Abstract

Heterochromatin protein 1 binding protein 3 (HP1BP3) is a recently described histone H1-related protein with roles in chromatin structure and transcriptional regulation. To explore the potential physiological role of HP1BP3, we have previously described an Hp1bp3(-/-) mouse model with reduced postnatal viability and growth. We now find that these mice are proportionate dwarfs, with reduction in body weight, body length, and organ weight. In addition to their small size, microcomputed tomography analysis showed that Hp1bp3(-/-) mice present a dramatic impairment of their bone development and structure. By 3 weeks of age, mice of both sexes have severely impaired cortical and trabecular bone, and these defects persist into adulthood and beyond. Primary cultures of both osteoblasts and osteoclasts from Hp1bp3(-/-) bone marrow and splenocytes, respectively, showed normal differentiation and function, strongly suggesting that the impaired bone accrual is due to noncell autonomous systemic cues in vivo. One major endocrine pathway regulating both body growth and bone acquisition is the IGF regulatory system, composed of IGF-1, the IGF receptors, and the IGF-binding proteins (IGFBPs). At 3 weeks of age, Hp1bp3(-/-) mice exhibited a 60% reduction in circulating IGF-1 and a 4-fold increase in the levels of IGFBP-1 and IGFBP-2. These alterations were reflected in similar changes in the hepatic transcripts of the Igf1, Igfbp1, and Igfbp2 genes. Collectively, these results suggest that HP1BP3 plays a key role in normal growth and bone development by regulating transcription of endocrine IGF-1 components.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26402843      PMCID: PMC5393342          DOI: 10.1210/en.2015-1668

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  57 in total

Review 1.  The role of liver-derived insulin-like growth factor-I.

Authors:  Claes Ohlsson; Subburaman Mohan; Klara Sjögren; Asa Tivesten; Jörgen Isgaard; Olle Isaksson; John-Olov Jansson; Johan Svensson
Journal:  Endocr Rev       Date:  2009-07-09       Impact factor: 19.871

2.  A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse).

Authors:  Y Zhou; B C Xu; H G Maheshwari; L He; M Reed; M Lozykowski; S Okada; L Cataldo; K Coschigamo; T E Wagner; G Baumann; J J Kopchick
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

3.  Nonsense mutation in the human growth hormone-releasing hormone receptor causes growth failure analogous to the little (lit) mouse.

Authors:  M P Wajnrajch; J M Gertner; M D Harbison; S C Chua; R L Leibel
Journal:  Nat Genet       Date:  1996-01       Impact factor: 38.330

4.  Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth.

Authors:  F Lupu; J D Terwilliger; K Lee; G V Segre; A Efstratiadis
Journal:  Dev Biol       Date:  2001-01-01       Impact factor: 3.582

Review 5.  Genetic regulation of bone mass and susceptibility to osteoporosis.

Authors:  Stuart H Ralston; Benoit de Crombrugghe
Journal:  Genes Dev       Date:  2006-09-15       Impact factor: 11.361

6.  Normal growth and development in the absence of hepatic insulin-like growth factor I.

Authors:  S Yakar; J L Liu; B Stannard; A Butler; D Accili; B Sauer; D LeRoith
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

Review 7.  The effect of GH and IGF1 on linear growth and skeletal development and their modulation by SOCS proteins.

Authors:  S F Ahmed; C Farquharson
Journal:  J Endocrinol       Date:  2010-07-14       Impact factor: 4.286

8.  Circulating levels of IGF-1 directly regulate bone growth and density.

Authors:  Shoshana Yakar; Clifford J Rosen; Wesley G Beamer; Cheryl L Ackert-Bicknell; Yiping Wu; Jun-Li Liu; Guck T Ooi; Jennifer Setser; Jan Frystyk; Yves R Boisclair; Derek LeRoith
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

9.  Gender-specific changes in bone turnover and skeletal architecture in igfbp-2-null mice.

Authors:  V E DeMambro; D R Clemmons; L G Horton; M L Bouxsein; T L Wood; W G Beamer; E Canalis; C J Rosen
Journal:  Endocrinology       Date:  2008-02-14       Impact factor: 4.736

10.  A potentially deleterious role of IGFBP-2 on bone density in aging men and women.

Authors:  Shreyasee Amin; B Lawrence Riggs; Elizabeth J Atkinson; Ann L Oberg; L Joseph Melton; Sundeep Khosla
Journal:  J Bone Miner Res       Date:  2004-03-22       Impact factor: 6.741

View more
  10 in total

1.  The expression of IGFBP-5 in the reproductive axis and effect on the onset of puberty in female rats.

Authors:  Zhiqiu Yao; Maosen Lin; Tao Lin; Xinbao Gong; Pin Qin; Hailing Li; Tiezhu Kang; Jing Ye; Yanyun Zhu; Qiwen Hong; Ya Liu; Yunsheng Li; Juhua Wang; Fugui Fang
Journal:  Reprod Biol Endocrinol       Date:  2022-07-12       Impact factor: 4.982

2.  Systems genetics identifies Hp1bp3 as a novel modulator of cognitive aging.

Authors:  Sarah M Neuner; Benjamin P Garfinkel; Lynda A Wilmott; Bogna M Ignatowska-Jankowska; Ami Citri; Joseph Orly; Lu Lu; Rupert W Overall; Megan K Mulligan; Gerd Kempermann; Robert W Williams; Kristen M S O'Connell; Catherine C Kaczorowski
Journal:  Neurobiol Aging       Date:  2016-06-17       Impact factor: 4.673

3.  HP1BP3, a Chromatin Retention Factor for Co-transcriptional MicroRNA Processing.

Authors:  Haoming Liu; Chunyang Liang; Rahul K Kollipara; Masayuki Matsui; Xiong Ke; Byung-Cheon Jeong; Zhiqiang Wang; Kyoung Shin Yoo; Gaya P Yadav; Lisa N Kinch; Nicholas V Grishin; Yunsun Nam; David R Corey; Ralf Kittler; Qinghua Liu
Journal:  Mol Cell       Date:  2016-07-14       Impact factor: 17.970

4.  HP1BP3 promotes tumor growth and metastasis by upregulating miR-23a to target TRAF5 in esophageal squamous cell carcinoma.

Authors:  Mingyi Shang; Li Weng; Shaoqiu Wu; Bingyan Liu; Xiang Yin; Zhongmin Wang; Aiwu Mao
Journal:  Am J Cancer Res       Date:  2021-06-15       Impact factor: 6.166

5.  Scalable control of developmental timetables by epigenetic switching networks.

Authors:  Phuc Nguyen; Nicholas A Pease; Hao Yuan Kueh
Journal:  J R Soc Interface       Date:  2021-07-21       Impact factor: 4.293

6.  The novel transcriptional factor HP1BP3 negatively regulates Hsp70 transcription in Crassostrea hongkongensis.

Authors:  Delin Xu; Qin Yang; Miao Cui; Qizhong Zhang
Journal:  Sci Rep       Date:  2017-05-03       Impact factor: 4.379

7.  Knockdown of heterochromatin protein 1 binding protein 3 recapitulates phenotypic, cellular, and molecular features of aging.

Authors:  Sarah M Neuner; Shengyuan Ding; Catherine C Kaczorowski
Journal:  Aging Cell       Date:  2018-12-13       Impact factor: 9.304

8.  What do DNA methylation studies tell us about depression? A systematic review.

Authors:  Muzi Li; Carl D'Arcy; Xintong Li; Tieyuan Zhang; Ridha Joober; Xiangfei Meng
Journal:  Transl Psychiatry       Date:  2019-02-04       Impact factor: 6.222

9.  A critical role of telomere chromatin compaction in ALT tumor cell growth.

Authors:  Guang Shi; Yang Hu; Xing Zhu; Yuanling Jiang; Junjie Pang; Chuanle Wang; Wenjun Huang; Yong Zhao; Wenbin Ma; Dan Liu; Junjiu Huang; Zhou Songyang
Journal:  Nucleic Acids Res       Date:  2020-06-19       Impact factor: 16.971

10.  A peptide containing the receptor binding site of insulin-like growth factor binding protein-2 enhances bone mass in ovariectomized rats.

Authors:  Gang Xi; Christine Wai; Clifford J Rosen; David R Clemmons
Journal:  Bone Res       Date:  2018-08-14       Impact factor: 13.567

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.